ÂÜÀòÂÒÂ×

Mazin Derzi serves as the Senior Vice President and Head of Preclinical Sciences at Vertex Pharmaceuticals since August 2021, where responsibility encompasses preclinical strategy and development to transition drug candidates from discovery to clinical phases, leading a global team across multiple sites. Prior to Vertex, Mazin held various significant roles at Pfizer from May 2008 to August 2021, including Vice President of Regulatory and Immunosafety Sciences, overseeing a large global organization and contributing to regulatory strategy and compliance. Additional experience includes positions at RECKITT BENCKISER GROUP PLC, Unilever, Bayer Crop Science, the UK Department of Health, and the Health and Safety Executive, building a robust foundation in toxicology and regulatory affairs throughout a diverse career spanning several prominent organizations.